APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence Drug Discovery Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Artificial Intelligence Drug Discovery Platform Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchArtificial Intelligence Drug Discovery Platform Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence Drug Discovery Platform Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence Drug Discovery Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence Drug Discovery Platform Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence Drug Discovery Platform Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Artificial Intelligence Drug Discovery Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Artificial Intelligence Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artificial Intelligence Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Intelligence Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Artificial Intelligence Drug Discovery Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Artificial Intelligence Drug Discovery Platform market include BenevolentAI, Schrödinger, Numerion Labs, XtalPi, Tencent, NVIDIA, Insilico Medicine, Iambic Therapeutics and insitro, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Artificial Intelligence Drug Discovery Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Intelligence Drug Discovery Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Intelligence Drug Discovery Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Artificial Intelligence Drug Discovery Platform market.

Artificial Intelligence Drug Discovery Platform Segment by Company

BenevolentAI

Schrödinger

Numerion Labs

XtalPi

Tencent

NVIDIA

Insilico Medicine

Iambic Therapeutics

insitro

Valo Health

Genesis

DeepCure

Nimbus Therapeutics

Absci

Owkin

Eli Lilly

Recursion

Artificial Intelligence Drug Discovery Platform Segment by Type

Small Molecule Platform

Biomacromolecule Platform

Others

Artificial Intelligence Drug Discovery Platform Segment by Application

Pharmaceutical Companies

Research Institutions

Others

Artificial Intelligence Drug Discovery Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artificial Intelligence Drug Discovery Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Artificial Intelligence Drug Discovery Platform key companies, revenue, market share, and recent developments.

3. To split the Artificial Intelligence Drug Discovery Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Artificial Intelligence Drug Discovery Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artificial Intelligence Drug Discovery Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Artificial Intelligence Drug Discovery Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence Drug Discovery Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence Drug Discovery Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence Drug Discovery Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Intelligence Drug Discovery Platform industry.

Chapter 3: Detailed analysis of Artificial Intelligence Drug Discovery Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Artificial Intelligence Drug Discovery Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Artificial Intelligence Drug Discovery Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artificial Intelligence Drug Discovery Platform Industry Trends Table 2. Artificial Intelligence Drug Discovery Platform Industry Drivers Table 3. Artificial Intelligence Drug Discovery Platform Industry Opportunities and Challenges Table 4. Artificial Intelligence Drug Discovery Platform Industry Restraints Table 5. Global Artificial Intelligence Drug Discovery Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artificial Intelligence Drug Discovery Platform Revenue Share by Company (2021-2026) Table 7. Global Artificial Intelligence Drug Discovery Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Artificial Intelligence Drug Discovery Platform Key Company Manufacturing Base & Headquarters Table 9. Global Artificial Intelligence Drug Discovery Platform Company, Product Type & Application Table 10. Global Artificial Intelligence Drug Discovery Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Artificial Intelligence Drug Discovery Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Small Molecule Platform Table 15. Significant Companies of Biomacromolecule Platform Table 16. Significant Companies of Others Table 17. Global Artificial Intelligence Drug Discovery Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Artificial Intelligence Drug Discovery Platform Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Artificial Intelligence Drug Discovery Platform Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Artificial Intelligence Drug Discovery Platform Sales Value Share by Type (2021-2026) Table 21. Global Artificial Intelligence Drug Discovery Platform Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Pharmaceutical Companies Table 23. Significant Companies of Research Institutions Table 24. Significant Companies of Others Table 25. Global Artificial Intelligence Drug Discovery Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Artificial Intelligence Drug Discovery Platform Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Artificial Intelligence Drug Discovery Platform Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Artificial Intelligence Drug Discovery Platform Sales Value Share by Application (2021-2026) Table 29. Global Artificial Intelligence Drug Discovery Platform Sales Value Share by Application (2027-2032) Table 30. Global Artificial Intelligence Drug Discovery Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Artificial Intelligence Drug Discovery Platform Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Artificial Intelligence Drug Discovery Platform Sales Value Share by Region (2021-2026) Table 33. Global Artificial Intelligence Drug Discovery Platform Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Artificial Intelligence Drug Discovery Platform Sales Value Share by Region (2027-2032) Table 35. Global Artificial Intelligence Drug Discovery Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Artificial Intelligence Drug Discovery Platform Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Artificial Intelligence Drug Discovery Platform Sales Value Market Share by Country (2021-2026) Table 38. Global Artificial Intelligence Drug Discovery Platform Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Artificial Intelligence Drug Discovery Platform Sales Value Market Share by Country (2027-2032) Table 40. BenevolentAI Company Information Table 41. BenevolentAI Business Overview Table 42. BenevolentAI Artificial Intelligence Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. BenevolentAI Artificial Intelligence Drug Discovery Platform Product Portfolio Table 44. BenevolentAI Recent Development Table 45. Schrödinger Company Information Table 46. Schrödinger Business Overview Table 47. Schrödinger Artificial Intelligence Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Schrödinger Artificial Intelligence Drug Discovery Platform Product Portfolio Table 49. Schrödinger Recent Development Table 50. Numerion Labs Company Information Table 51. Numerion Labs Business Overview Table 52. Numerion Labs Artificial Intelligence Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Numerion Labs Artificial Intelligence Drug Discovery Platform Product Portfolio Table 54. Numerion Labs Recent Development Table 55. XtalPi Company Information Table 56. XtalPi Business Overview Table 57. XtalPi Artificial Intelligence Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. XtalPi Artificial Intelligence Drug Discovery Platform Product Portfolio Table 59. XtalPi Recent Development Table 60. Tencent Company Information Table 61. Tencent Business Overview Table 62. Tencent Artificial Intelligence Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Tencent Artificial Intelligence Drug Discovery Platform Product Portfolio Table 64. Tencent Recent Development Table 65. NVIDIA Company Information Table 66. NVIDIA Business Overview Table 67. NVIDIA Artificial Intelligence Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. NVIDIA Artificial Intelligence Drug Discovery Platform Product Portfolio Table 69. NVIDIA Recent Development Table 70. Insilico Medicine Company Information Table 71. Insilico Medicine Business Overview Table 72. Insilico Medicine Artificial Intelligence Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Insilico Medicine Artificial Intelligence Drug Discovery Platform Product Portfolio Table 74. Insilico Medicine Recent Development Table 75. Iambic Therapeutics Company Information Table 76. Iambic Therapeutics Business Overview Table 77. Iambic Therapeutics Artificial Intelligence Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Iambic Therapeutics Artificial Intelligence Drug Discovery Platform Product Portfolio Table 79. Iambic Therapeutics Recent Development Table 80. insitro Company Information Table 81. insitro Business Overview Table 82. insitro Artificial Intelligence Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. insitro Artificial Intelligence Drug Discovery Platform Product Portfolio Table 84. insitro Recent Development Table 85. Valo Health Company Information Table 86. Valo Health Business Overview Table 87. Valo Health Artificial Intelligence Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Valo Health Artificial Intelligence Drug Discovery Platform Product Portfolio Table 89. Valo Health Recent Development Table 90. Genesis Company Information Table 91. Genesis Business Overview Table 92. Genesis Artificial Intelligence Drug Discovery Platform Sales (Unit), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Genesis Artificial Intelligence Drug Discovery Platform Product Portfolio Table 94. Genesis Recent Development Table 95. DeepCure Company Information Table 96. DeepCure Business Overview Table 97. DeepCure Artificial Intelligence Drug Discovery Platform Sales (Unit), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. DeepCure Artificial Intelligence Drug Discovery Platform Product Portfolio Table 99. DeepCure Recent Development Table 100. Nimbus Therapeutics Company Information Table 101. Nimbus Therapeutics Business Overview Table 102. Nimbus Therapeutics Artificial Intelligence Drug Discovery Platform Sales (Unit), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Nimbus Therapeutics Artificial Intelligence Drug Discovery Platform Product Portfolio Table 104. Nimbus Therapeutics Recent Development Table 105. Absci Company Information Table 106. Absci Business Overview Table 107. Absci Artificial Intelligence Drug Discovery Platform Sales (Unit), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Absci Artificial Intelligence Drug Discovery Platform Product Portfolio Table 109. Absci Recent Development Table 110. Owkin Company Information Table 111. Owkin Business Overview Table 112. Owkin Artificial Intelligence Drug Discovery Platform Sales (Unit), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Owkin Artificial Intelligence Drug Discovery Platform Product Portfolio Table 114. Owkin Recent Development Table 115. Eli Lilly Company Information Table 116. Eli Lilly Business Overview Table 117. Eli Lilly Artificial Intelligence Drug Discovery Platform Sales (Unit), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Eli Lilly Artificial Intelligence Drug Discovery Platform Product Portfolio Table 119. Eli Lilly Recent Development Table 120. Recursion Company Information Table 121. Recursion Business Overview Table 122. Recursion Artificial Intelligence Drug Discovery Platform Sales (Unit), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Recursion Artificial Intelligence Drug Discovery Platform Product Portfolio Table 124. Recursion Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Artificial Intelligence Drug Discovery Platform Product Image Figure 2. Global Artificial Intelligence Drug Discovery Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Intelligence Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Artificial Intelligence Drug Discovery Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Small Molecule Platform Image Figure 8. Biomacromolecule Platform Image Figure 9. Others Image Figure 10. Global Artificial Intelligence Drug Discovery Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Artificial Intelligence Drug Discovery Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Artificial Intelligence Drug Discovery Platform Sales Value Share by Type (2021-2032) Figure 13. Pharmaceutical Companies Image Figure 14. Research Institutions Image Figure 15. Others Image Figure 16. Global Artificial Intelligence Drug Discovery Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Artificial Intelligence Drug Discovery Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Artificial Intelligence Drug Discovery Platform Sales Value Share by Application (2021-2032) Figure 19. Global Artificial Intelligence Drug Discovery Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Artificial Intelligence Drug Discovery Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Artificial Intelligence Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 22. North America Artificial Intelligence Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Artificial Intelligence Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Artificial Intelligence Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Artificial Intelligence Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Artificial Intelligence Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Artificial Intelligence Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 28. South America Artificial Intelligence Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Artificial Intelligence Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Artificial Intelligence Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Small Molecule Platform
  • Biomacromolecule Platform
  • Others
Applications
  • Pharmaceutical Companies
  • Research Institutions
  • Others
Companies covered
  • BenevolentAI
  • Schrödinger
  • Numerion Labs
  • XtalPi
  • Tencent
  • NVIDIA
  • Insilico Medicine
  • Iambic Therapeutics
  • insitro
  • Valo Health
  • Genesis
  • DeepCure
  • Nimbus Therapeutics
  • Absci
  • Owkin
  • Eli Lilly
  • Recursion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Artificial Intelligence Drug Discovery Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Artificial Intelligence Drug Discovery Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Artificial Intelligence Drug Discovery Platform Market Dynamics
  1. 2.1 Artificial Intelligence Drug Discovery Platform Industry Trends
  2. 2.2 Artificial Intelligence Drug Discovery Platform Industry Drivers
  3. 2.3 Artificial Intelligence Drug Discovery Platform Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence Drug Discovery Platform Industry Restraints
3 Artificial Intelligence Drug Discovery Platform Market by Company
  1. 3.1 Global Artificial Intelligence Drug Discovery Platform Company Revenue Ranking in 2025
  2. 3.2 Global Artificial Intelligence Drug Discovery Platform Revenue by Company (2021-2026)
  3. 3.3 Global Artificial Intelligence Drug Discovery Platform Company Ranking (2024-2026)
  4. 3.4 Global Artificial Intelligence Drug Discovery Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Artificial Intelligence Drug Discovery Platform Company Product Type and Application
  6. 3.6 Global Artificial Intelligence Drug Discovery Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Artificial Intelligence Drug Discovery Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Artificial Intelligence Drug Discovery Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Artificial Intelligence Drug Discovery Platform Market by Type
  1. 4.1 Artificial Intelligence Drug Discovery Platform Type Introduction
  2. 4.1.1 Small Molecule Platform
  3. 4.1.2 Biomacromolecule Platform
  4. 4.1.3 Others
  5. 4.2 Global Artificial Intelligence Drug Discovery Platform Sales Value by Type
  6. 4.2.1 Global Artificial Intelligence Drug Discovery Platform Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Artificial Intelligence Drug Discovery Platform Sales Value by Type (2021-2032)
  8. 4.2.3 Global Artificial Intelligence Drug Discovery Platform Sales Value Share by Type (2021-2032)
5 Artificial Intelligence Drug Discovery Platform Market by Application
  1. 5.1 Artificial Intelligence Drug Discovery Platform Application Introduction
  2. 5.1.1 Pharmaceutical Companies
  3. 5.1.2 Research Institutions
  4. 5.1.3 Others
  5. 5.2 Global Artificial Intelligence Drug Discovery Platform Sales Value by Application
  6. 5.2.1 Global Artificial Intelligence Drug Discovery Platform Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Artificial Intelligence Drug Discovery Platform Sales Value by Application (2021-2032)
  8. 5.2.3 Global Artificial Intelligence Drug Discovery Platform Sales Value Share by Application (2021-2032)
6 Artificial Intelligence Drug Discovery Platform Regional Value Analysis
  1. 6.1 Global Artificial Intelligence Drug Discovery Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Intelligence Drug Discovery Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Artificial Intelligence Drug Discovery Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Artificial Intelligence Drug Discovery Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Artificial Intelligence Drug Discovery Platform Sales Value (2021-2032)
  7. 6.3.2 North America Artificial Intelligence Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Artificial Intelligence Drug Discovery Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Artificial Intelligence Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Artificial Intelligence Drug Discovery Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Artificial Intelligence Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Artificial Intelligence Drug Discovery Platform Sales Value (2021-2032)
  16. 6.6.2 South America Artificial Intelligence Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Artificial Intelligence Drug Discovery Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Artificial Intelligence Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
7 Artificial Intelligence Drug Discovery Platform Country-level Value Analysis
  1. 7.1 Global Artificial Intelligence Drug Discovery Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artificial Intelligence Drug Discovery Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Artificial Intelligence Drug Discovery Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Artificial Intelligence Drug Discovery Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Artificial Intelligence Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Artificial Intelligence Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Artificial Intelligence Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BenevolentAI
  2. 8.1.1 BenevolentAI Company Information
  3. 8.1.2 BenevolentAI Business Overview
  4. 8.1.3 BenevolentAI Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BenevolentAI Artificial Intelligence Drug Discovery Platform Product Portfolio
  6. 8.1.5 BenevolentAI Recent Developments
  7. 8.2 Schrödinger
  8. 8.2.1 Schrödinger Company Information
  9. 8.2.2 Schrödinger Business Overview
  10. 8.2.3 Schrödinger Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Schrödinger Artificial Intelligence Drug Discovery Platform Product Portfolio
  12. 8.2.5 Schrödinger Recent Developments
  13. 8.3 Numerion Labs
  14. 8.3.1 Numerion Labs Company Information
  15. 8.3.2 Numerion Labs Business Overview
  16. 8.3.3 Numerion Labs Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Numerion Labs Artificial Intelligence Drug Discovery Platform Product Portfolio
  18. 8.3.5 Numerion Labs Recent Developments
  19. 8.4 XtalPi
  20. 8.4.1 XtalPi Company Information
  21. 8.4.2 XtalPi Business Overview
  22. 8.4.3 XtalPi Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 XtalPi Artificial Intelligence Drug Discovery Platform Product Portfolio
  24. 8.4.5 XtalPi Recent Developments
  25. 8.5 Tencent
  26. 8.5.1 Tencent Company Information
  27. 8.5.2 Tencent Business Overview
  28. 8.5.3 Tencent Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Tencent Artificial Intelligence Drug Discovery Platform Product Portfolio
  30. 8.5.5 Tencent Recent Developments
  31. 8.6 NVIDIA
  32. 8.6.1 NVIDIA Company Information
  33. 8.6.2 NVIDIA Business Overview
  34. 8.6.3 NVIDIA Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NVIDIA Artificial Intelligence Drug Discovery Platform Product Portfolio
  36. 8.6.5 NVIDIA Recent Developments
  37. 8.7 Insilico Medicine
  38. 8.7.1 Insilico Medicine Company Information
  39. 8.7.2 Insilico Medicine Business Overview
  40. 8.7.3 Insilico Medicine Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Insilico Medicine Artificial Intelligence Drug Discovery Platform Product Portfolio
  42. 8.7.5 Insilico Medicine Recent Developments
  43. 8.8 Iambic Therapeutics
  44. 8.8.1 Iambic Therapeutics Company Information
  45. 8.8.2 Iambic Therapeutics Business Overview
  46. 8.8.3 Iambic Therapeutics Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Iambic Therapeutics Artificial Intelligence Drug Discovery Platform Product Portfolio
  48. 8.8.5 Iambic Therapeutics Recent Developments
  49. 8.9 insitro
  50. 8.9.1 insitro Company Information
  51. 8.9.2 insitro Business Overview
  52. 8.9.3 insitro Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 insitro Artificial Intelligence Drug Discovery Platform Product Portfolio
  54. 8.9.5 insitro Recent Developments
  55. 8.10 Valo Health
  56. 8.10.1 Valo Health Company Information
  57. 8.10.2 Valo Health Business Overview
  58. 8.10.3 Valo Health Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Valo Health Artificial Intelligence Drug Discovery Platform Product Portfolio
  60. 8.10.5 Valo Health Recent Developments
  61. 8.11 Genesis
  62. 8.11.1 Genesis Company Information
  63. 8.11.2 Genesis Business Overview
  64. 8.11.3 Genesis Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Genesis Artificial Intelligence Drug Discovery Platform Product Portfolio
  66. 8.11.5 Genesis Recent Developments
  67. 8.12 DeepCure
  68. 8.12.1 DeepCure Company Information
  69. 8.12.2 DeepCure Business Overview
  70. 8.12.3 DeepCure Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 DeepCure Artificial Intelligence Drug Discovery Platform Product Portfolio
  72. 8.12.5 DeepCure Recent Developments
  73. 8.13 Nimbus Therapeutics
  74. 8.13.1 Nimbus Therapeutics Company Information
  75. 8.13.2 Nimbus Therapeutics Business Overview
  76. 8.13.3 Nimbus Therapeutics Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Nimbus Therapeutics Artificial Intelligence Drug Discovery Platform Product Portfolio
  78. 8.13.5 Nimbus Therapeutics Recent Developments
  79. 8.14 Absci
  80. 8.14.1 Absci Company Information
  81. 8.14.2 Absci Business Overview
  82. 8.14.3 Absci Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Absci Artificial Intelligence Drug Discovery Platform Product Portfolio
  84. 8.14.5 Absci Recent Developments
  85. 8.15 Owkin
  86. 8.15.1 Owkin Company Information
  87. 8.15.2 Owkin Business Overview
  88. 8.15.3 Owkin Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Owkin Artificial Intelligence Drug Discovery Platform Product Portfolio
  90. 8.15.5 Owkin Recent Developments
  91. 8.16 Eli Lilly
  92. 8.16.1 Eli Lilly Company Information
  93. 8.16.2 Eli Lilly Business Overview
  94. 8.16.3 Eli Lilly Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Eli Lilly Artificial Intelligence Drug Discovery Platform Product Portfolio
  96. 8.16.5 Eli Lilly Recent Developments
  97. 8.17 Recursion
  98. 8.17.1 Recursion Company Information
  99. 8.17.2 Recursion Business Overview
  100. 8.17.3 Recursion Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Recursion Artificial Intelligence Drug Discovery Platform Product Portfolio
  102. 8.17.5 Recursion Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst